Outlook Therapeutics (OTLK) Payables: 2015-2020
Historic Payables for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to $8.6 million.
- Outlook Therapeutics' Payables rose 30.63% to $8.6 million in Q2 2020 from the same period last year, while for Jun 2020 it was $27.6 million, marking a year-over-year decrease of 15.96%. This contributed to the annual value of $5.9 million for FY2019, which is 28.36% down from last year.
- According to the latest figures from Q2 2020, Outlook Therapeutics' Payables is $8.6 million, which was up 24.60% from $6.9 million recorded in Q1 2020.
- Outlook Therapeutics' 5-year Payables high stood at $24.1 million for Q1 2016, and its period low was $5.9 million during Q3 2019.
- In the last 3 years, Outlook Therapeutics' Payables had a median value of $8.1 million in 2018 and averaged $7.7 million.
- As far as peak fluctuations go, Outlook Therapeutics' Payables crashed by 65.14% in 2016, and later skyrocketed by 79.35% in 2017.
- Quarterly analysis of 5 years shows Outlook Therapeutics' Payables stood at $15.7 million in 2016, then plummeted by 47.37% to $8.2 million in 2017, then rose by 12.94% to $9.3 million in 2018, then crashed by 33.61% to $6.2 million in 2019, then surged by 30.63% to $8.6 million in 2020.
- Its last three reported values are $8.6 million in Q2 2020, $6.9 million for Q1 2020, and $6.2 million during Q4 2019.